Oxaliplatin-Induced Neuropathy in Colorectal Cancer
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Oxaliplatin use in palliative and adjuvant treatment of colon cancer is frequently limited by cumulative neurotoxicity, leading to reduced quality of life and decreased dose. The mechanism of this neurotoxicity is unclear, but may relate to neuronal voltage-gated sodium channels involving calcium chelation by a metabolite of the drug. Various preventative measures have been tested to reduce the incidence of neurotoxicity, including calcium and magnesium infusions, dose interruption of the drug, and prophylactic neuromodulatory agents. Despite the promising efficacy of these measures, they are not universally accepted. Less is known about the best way to treat established neurotoxicity, which is permanent in some patients, although venlafaxine has shown promise in small clinical trials. This paper analyzes the extent, cause and risk factors for neuropathy, and the potential preventative and therapeutic treatments for oxaliplatin-induced neuropathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Despite their efficacy, the use of these drugs is hindered by their severe side effects.”
From Hyaluronic a cid–doxorubicin nanoparticles for targeted treatment of colorectal cancer (2021) · cites this paper as [55]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
de Gramont, A., Figer, A., Seymour, M., Homerin, M., Hmissi, A., Cassidy, J., Boni, C., Cortes-Funes, H., Cervantes, A., Freyer, G., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.16.2938 · Cited by 3,815
Falcone, A., Ricci, S., Brunetti, I., Pfanner, E., Allegrini, G., Barbara, C., Crinò, L., Benedetti, G., Evangelista, W., Fanchini, L., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.0928 · Cited by 1,241
Research works printed but not linked: 57
- 10.1056/NEJMoa032709 · DOI · Paper page
- 10.1200/JCO.2006.08.1075 · DOI · Paper page
- 10.1093/jnci/djq456 · DOI · Paper page
- 2011, Current Oncology, 18, 18, 10.3747/co.v18i1.708 · DOI · Paper page
- 1998, Seminars in Oncology, 25, 4
- 10.1517/14656566.4.6.889 · DOI · Paper page
- 10.1345/aph.1E319 · DOI · Paper page
- 10.1016/j.ctrv.2008.01.003 · DOI · Paper page
- 10.1016/S0014-2999(00)00667-1 · DOI · Paper page
- 2001, Journal of Neurophysiology, 85, 2293, 10.1152/jn.2001.85.5.2293 · DOI · Paper page
- 10.1158/1078-0432.CCR-07-0660 · DOI
- 10.3816/CCC.2005.s.006 · DOI · Paper page
- 1999, Neurology, 53, 1660, 10.1212/WNL.53.8.1660 · DOI · Paper page
- 2003, Neurology, 61, 1297, 10.1212/01.WNL.0000092015.03923.19 · doi:10.1212/01.wnl.0000092015.03923.19
- 10.1200/JCO.2007.14.9898 · DOI · Paper page
- 10.1200/JCO.2010.31.5911 · DOI · Paper page
- 10.1200/JCO.2009.21.9220 · DOI · Paper page
- 10.1200/JCO.2006.08.6652 · DOI · Paper page
- 10.1080/02841860701355055 · DOI
- 10.1634/theoncologist.2010-0248 · DOI · Paper page
- 10.1093/annonc/mdp509 · DOI
- 10.1200/JCO.2006.06.9039 · DOI · Paper page
- 1999, EMBO Journal, 18, 1321, 10.1093/emboj/18.5.1321 · DOI · Paper page
- 10.1074/jbc.M301211200 · DOI · Paper page
- 10.1016/S0009-2797(97)00176-2 · DOI
- 10.1158/1078-0432.CCR-05-2076 · DOI · Paper page
- 10.1016/j.canep.2010.02.008 · DOI
- 10.1111/j.1468-1331.2010.02966.x · DOI
- Journal of Clinical Oncology, 28, 3583
- 10.1200/JCO.2005.03.0106 · DOI · Paper page
- 10.1200/JCO.2007.13.5251 · doi:10.1200/jco.2007.13.5251
- Journal of Clinical Oncology, 26, 4010
- 10.1038/sj.bjc.6605061 · DOI
- 10.1200/JCO.2009.23.4344 · DOI · Paper page
- Journal of Clinical Oncology, 28, 3501
- 2002, Seminars in Oncology, 29, 21, 10.1016/S0093-7754(02)90017-5 · doi:10.1016/s0093-7754(02)90017-5 · Paper page
- 10.1158/1078-0432.CCR-03-0666 · DOI
- 10.1016/j.ejca.2010.10.006 · doi:10.1016/j.ejca.2010.10.006
- 10.1200/JCO.2007.15.3767 · doi:10.1200/jco.2007.15.3767
- 10.1200/JCO.2002.07.061 · DOI · Paper page
- 10.1007/s00520-006-0018-9 · DOI
- 10.1634/theoncologist.12-3-312 · DOI · Paper page
- 2008, Ai Zheng, 27, 1117
- Journal of Clinical Oncology, 29, 9010
- 10.1007/s10637-006-9010-y · doi:10.1007/s10637-006-9010-y
- 10.1212/01.wnl.0000249344.99671.d4 · doi:10.1212/01.wnl.0000249344.99671.d4
- 2006, Clinical Colorectal Cancer, 6, 146, 10.3816/CCC.2006.n.032 · DOI
- 10.1097/00001813-200307000-00006 · DOI
- 10.1002/cncr.23482 · DOI · Paper page
- 10.1200/JCO.2011.34.8227 · DOI
- 10.1016/S0074-7742(07)82016-2 · DOI · Paper page
- 10.1006/toxs.1998.2558 · doi:10.1006/toxs.1998.2558
- 2005, International Journal of Immunopathology and Pharmacology, 18, 21, 10.1177/039463200501800104 · DOI
- 2006, Journal of Clinical Oncology, 24, 3507
- 10.1016/j.jpainsymman.2007.02.043 · DOI · Paper page
- Journal of Clinical Oncology, 19, 2937
- 10.1007/s00280-007-0584-7 · doi:10.1007/s00280-007-0584-7
Cited by
Chemotherapy-induced neuropathy: A comprehensive survey
Miltenburg, N. C., & Boogerd, W. (2014) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2014.04.004 · Cited by 431
Hyaluronic a cid–doxorubicin nanoparticles for targeted treatment of colorectal cancer
Pan, D. C., Krishnan, V., Salinas, A. K., Kim, J., Sun, T., Ravid, S., Peng, K., Wu, D., Nurunnabi, M., Nelson, J. A., et al. (2021) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10166 · Cited by 42
“Irinotecan also induces neutropenia and diarrhea.(26,54,55)”
Metadata
- Authors
- Weickhardt, A., Wells, K., & Messersmith, W.
- Affiliations
- Division of Medical Oncology, University of Colorado Cancer Center, Aurora, CO 80045, USA
- Venue
- Journal of Oncology
- Publisher
- Hindawi Limited
- Published
- 2011
- Volume
- 2011
- Pages
- 1-7
- ISSN
- 1687-8450
- 1687-8469
- Cited by
- 58
- References
- 2
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Oxaliplatin-Induced Neuropathy in Colorectal Cancer. https://app.cochat.ai/papers/10.1155/2011/201593
- The paper
- Weickhardt, A., Wells, K., & Messersmith, W. (2011). Oxaliplatin-Induced Neuropathy in Colorectal Cancer. Journal of Oncology. https://doi.org/10.1155/2011/201593
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.